XML 33 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments and Derivative Instruments (Tables)
3 Months Ended
Mar. 31, 2013
Financial Instruments and Derivative Instruments  
Schedule of fair value of financial assets and liabilities

 

 

 

 

Fair Value Measurements at March 31, 2013 Using:

 

 

 

 

 

Quoted Prices in
Active
Markets for Identical
Assets

 

Significant Other
Observable
Inputs

 

Significant
Unobservable
Inputs

 

 

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

(in millions)

 

Assets

 

 

 

 

 

 

 

 

 

Plan asset for deferred compensation(1)

 

$

4.3

 

$

4.3

 

$

 

$

 

Total assets

 

$

4.3

 

$

4.3

 

$

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

Plan liability for deferred compensation(2)

 

$

4.3

 

$

4.3

 

$

 

$

 

Contingent consideration(3)

 

5.0

 

 

 

5.0

 

Total liabilities

 

$

9.3

 

$

4.3

 

$

 

$

5.0

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at December 31, 2012 Using:

 

 

 

 

 

Quoted Prices in Active
Markets for Identical Assets

 

Significant Other
Observable
Inputs

 

Significant
Unobservable
Inputs

 

 

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

(in millions)

 

Assets

 

 

 

 

 

 

 

 

 

Plan asset for deferred compensation(1)

 

$

4.2

 

$

4.2

 

$

 

$

 

Total assets

 

$

4.2

 

$

4.2

 

$

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

Plan liability for deferred compensation(2)

 

$

4.2

 

$

4.2

 

$

 

$

 

Contingent consideration(3)

 

5.2

 

 

 

5.2

 

Total liabilities

 

$

9.4

 

$

4.2

 

$

 

$

5.2

 

 

 

(1)       Included in other, net on the Company’s consolidated balance sheet.

(2)       Included in accrued compensation and benefits on the Company’s consolidated balance sheet.

(3)       Included in other noncurrent liabilities and accrued expenses and other liabilities on the Company’s consolidated balance sheet.

 

Summary of the changes in fair value of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3)

 

 

 

 

Balance

 

Purchases,

 

Total realized and
unrealized gains
(losses) included in:

 

Balance

 

 

 

December 31,
2012

 

sales,
settlements, net

 

Earnings

 

Comprehensive
income

 

March 31,
2013

 

 

 

(in millions)

 

Contingent consideration

 

$

5.2

 

$

 

$

 

$

(0.2

)

$

5.0

 

 

Carrying amount and estimated fair market value of the company's long-term debt, including current portion

 

 

 

 

March 31,

 

December 31,

 

 

 

2013

 

2012

 

 

 

(in millions)

 

Carrying amount

 

$

383.8

 

$

384.6

 

Estimated fair value

 

$

418.6

 

$

420.8